Blog Post
A Framework for Trust: Understanding the FDA’s AI Risk-Based Credibility Assessment (Part 1 of 3)
Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...
Read More
Blog Post
Solving Drug Shortages With AI
Explore the positive impact of artificial intelligence (AI) on pharmaceutical manufacturing, addressing persistent drug shortages. Dive into the benefits of predictive analytics, quality control enhancements,...
Read More
Blog Post
The Power of AI Augmentation: Unraveling Insights through Human-Generated Unstructured Data
Introduction Artificial Intelligence (AI) has emerged as a game-changer, revolutionizing industries and transforming the way we live. Rather than replacing people, AI complements and augments...
Read More
Blog Post
Use of Artificial Intelligence and Machine Learning (AI/ML)
This article is the first of five (5) articles that fall under the umbrella of the paper “ISPE│GAMP5 – a risk-based approach to compliant gxp...
Read More